Edition:
United States

Insider Trading: Edwards Lifesciences Corp (EW)

EW on New York Consolidated

113.11USD
18 Aug 2017
Change (% chg)

$-0.46 (-0.41%)
Prev Close
$113.57
Open
$113.37
Day's High
$113.61
Day's Low
$112.34
Volume
1,134,626
Avg. Vol
1,339,522
52-wk High
$121.75
52-wk Low
$81.12

VON SCHACK WESLEY W

Institutional Holders

% Shares Owned: 86.57%
# of Holders: 998
Total Shares Held: 182,796,586
3 Mo. Net Change: 661,399
# New Positions: 103
# Closed Positions: 62
# Increased Positions: 383
# Reduced Positions: 401
# Net Buyers: -18

Officers & Directors

Name Age Since Current Position

Michael Mussallem

64 2000 Chairman of the Board, Chief Executive Officer

Scott Ullem

50 2014 Chief Financial Officer, Corporate Vice President

Donald Bobo

55 2007 Corporate Vice President - Heart Valve Therapy

Catherine Szyman

50 2015 Corporate Vice President- Critical Care

Patrick Verguet

59 2004 Corporate Vice President- Europe, Middle East and Africa

Huimin Wang

60 2010 Corporate Vice President- Japan, Asia and Pacific

Larry Wood

51 2007 Corporate Vice President - Transcatheter Heart Valve Therapy

Bernard Zovighian

49 2016 Corporate Vice President -Surgical Heart Valve Therapy

Kieran Gallahue

53 2015 Independent Director

Leslie Heisz

56 2016 Independent Director

William Link

71 2009 Independent Director

Steven Loranger

65 2016 Independent Director

Martha Marsh

68 2016 Independent Director

Nicholas Valeriani

60 2014 Independent Director

Wesley von Schack

72 2012 Presiding Independent Director

David Erickson

Vice President - Investor Relations